Trials / Sponsors / Nanjing Bioheng Biotech Co., Ltd.
Nanjing Bioheng Biotech Co., Ltd.
Industry · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. SLE, LN, ANCA Associated Vasculitis | EARLY_Phase 1 | 2025-07-24 |
| Active Not Recruiting | A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM Type 1 Diabetes | EARLY_Phase 1 | 2025-07-20 |
| Recruiting | Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases SLE, Systemic Sclerosis, IIM | EARLY_Phase 1 | 2025-01-03 |
| Recruiting | Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases SLE (Systemic Lupus), Systemic Sclerosis, ANCA Associated Vasculitis | EARLY_Phase 1 | 2024-09-14 |
| Suspended | Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases Systemic Lupus Erythematosus, Systemic Sclerosis, ANCA Associated Vasculitis | EARLY_Phase 1 | 2024-09-13 |
| Withdrawn | A Study of RD06-04 in Patients With Active Autoimmune Diseases SLE, Sclerosis, ANCA Associated Vasculitis | EARLY_Phase 1 | 2024-08-31 |